These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2734981)

  • 1. Cytogenetic characterization of several androgen responsive and unresponsive sublines of the human prostatic carcinoma cell line LNCaP.
    König JJ; Kamst E; Hagemeijer A; Romijn JC; Horoszewicz J; Schröder FH
    Urol Res; 1989; 17(2):79-86. PubMed ID: 2734981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines.
    König JJ; Teubel W; van Steenbrugge GJ; Romijn JC; Hagemeijer A
    Urol Res; 1999; 27(1):3-8. PubMed ID: 10092147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.
    Wu HC; Hsieh JT; Gleave ME; Brown NM; Pathak S; Chung LW
    Int J Cancer; 1994 May; 57(3):406-12. PubMed ID: 8169003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.
    van Steenbrugge GJ; Groen M; van Dongen JW; Bolt J; van der Korput H; Trapman J; Hasenson M; Horoszewicz J
    Urol Res; 1989; 17(2):71-7. PubMed ID: 2660395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.
    He WW; Sciavolino PJ; Wing J; Augustus M; Hudson P; Meissner PS; Curtis RT; Shell BK; Bostwick DG; Tindall DJ; Gelmann EP; Abate-Shen C; Carter KC
    Genomics; 1997 Jul; 43(1):69-77. PubMed ID: 9226374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high-resolution study of chromosome changes in a human prostatic carcinoma cell line (LNCaP).
    Gibas Z; Becher R; Kawinski E; Horoszewicz J; Sandberg AA
    Cancer Genet Cytogenet; 1984 Apr; 11(4):399-404. PubMed ID: 6584201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer.
    Pang ST; Weng WH; Flores-Morales A; Johansson B; Pourian MR; Nilsson P; Pousette A; Larsson C; Norstedt G
    Prostate; 2006 Feb; 66(2):157-72. PubMed ID: 16173030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
    Miyake H; Hara I; Gleave ME; Eto H
    Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased androgen-responsive growth of human prostate cancer is associated with increased genetic alterations.
    Karan D; Schmied BM; Dave BJ; Wittel UA; Lin MF; Batra SK
    Clin Cancer Res; 2001 Nov; 7(11):3472-80. PubMed ID: 11705865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.
    van Steenbrugge GJ; van Uffelen CJ; Bolt J; Schröder FH
    J Steroid Biochem Mol Biol; 1991; 40(1-3):207-14. PubMed ID: 1958522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line.
    Bae VL; Jackson-Cook CK; Maygarden SJ; Plymate SR; Chen J; Ware JL
    Prostate; 1998 Mar; 34(4):275-82. PubMed ID: 9496902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early gene expression during androgen-induced inhibition of proliferation of prostate cancer cells: a new suppressor candidate on chromosome 13, in the BRCA2-Rb1 locus.
    Geck P; Szelei J; Jimenez J; Sonnenschein C; Soto AM
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):41-50. PubMed ID: 10215036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.
    Nesslinger NJ; Shi XB; deVere White RW
    Cancer Res; 2003 May; 63(9):2228-33. PubMed ID: 12727844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of 57 primary prostatic adenocarcinomas.
    Lundgren R; Mandahl N; Heim S; Limon J; Henrikson H; Mitelman F
    Genes Chromosomes Cancer; 1992 Jan; 4(1):16-24. PubMed ID: 1377005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.
    Hyytinen ER; Thalmann GN; Zhau HE; Karhu R; Kallioniemi OP; Chung LW; Visakorpi T
    Br J Cancer; 1997; 75(2):190-5. PubMed ID: 9010025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping.
    Pan Y; Kytölä S; Farnebo F; Wang N; Lui WO; Nupponen N; Isola J; Visakorpi T; Bergerheim US; Larsson C
    Cytogenet Cell Genet; 1999; 87(3-4):225-32. PubMed ID: 10702678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
    Jiang F; Wang Z
    Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer.
    Thalmann GN; Anezinis PE; Chang SM; Zhau HE; Kim EE; Hopwood VL; Pathak S; von Eschenbach AC; Chung LW
    Cancer Res; 1994 May; 54(10):2577-81. PubMed ID: 8168083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression.
    Bandyk MG; Zhao L; Troncoso P; Pisters LL; Palmer JL; von Eschenbach AC; Chung LW; Liang JC
    Genes Chromosomes Cancer; 1994 Jan; 9(1):19-27. PubMed ID: 7507696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor.
    Zhao X; van Steenbrugge GJ; Schröder FH
    Urol Res; 1992; 20(3):193-7. PubMed ID: 1615580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.